Results 41 to 50 of about 608,859 (140)

Pyruvate dehydrogenase : its structure, function and interactions within the pyruvate dehydrogenase multienzyme complex [PDF]

open access: yes, 2002
Pyruvate dehydrogenase multi-enzyme complex (PDHC) is member of a family of multienzyme complexes that catalyse the irreversible decarboxylation of various 2-oxoacid substrates to their corresponding acyl-CoA derivatives, NADH and C02.
Hengeveld, A.F.
core  

Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation.

open access: yes, 2003
Item does not contain fulltextA boy with recurrent episodes of hypoglycaemia and ataxia, microcephaly, mental retardation, permanent lactic acidaemia, intermittent 2-oxoglutaric aciduria as well as elevation of serum branched chain amino acids was ...
Heuvel, L.P.W.J. van den   +12 more
core   +1 more source

Structural and Biochemical Investigation of Selected Pathogenic Mutants of the Human Dihydrolipoamide Dehydrogenase

open access: yes, 2023
Clinically relevant disease causing variants of the human dihydrolipoamide dehydrogenase hLADH, hE3 , a common component of the mitochondrial amp; 945; keto acid dehydrogenase complexes, were characterized using a multipronged approach to unravel the ...
Zrupko, E.   +17 more
core   +1 more source

Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2 [PDF]

open access: yes, 1999
Deficiency of 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) in humans leads to the syndrome of apparent mineralocorticoid excess (SAME), in which cortisol illicitly occupies mineralocorticoid receptors, causing sodium retention, hypokalemia ...
Mullins, A J   +18 more
core   +1 more source

Neointimal Hyperplasia and Restenosis: Epidemiology, Pathophysiology, Animal Models, Clinical Features, Diagnosis, and Management

open access: yesMedComm, Volume 7, Issue 11, November 2026.
The overall graphical diagram to summarize the pathological characteristics, pathogenesis, clinical manifestation, preclinical animal models, diagnostic methods, and intervention strategies for neointimal hyperplasia. Neointimal hyperplasia results from excessive proliferation and intimal migration of vascular smooth muscle cells (VSMCs) in the ...
Kaixu Wang   +6 more
wiley   +1 more source

Isolation and characterisation of a novel dihydrolipoamide dehydrogenase from pea chloroplasts [PDF]

open access: yes, 1997
Dihydrolipoamide dehydrogenase (E3) is a common component of the three ?-ketoacid dehydrogenase complexes oxidising pyruvate, 2-oxoglutarate, and the branched chain 2-oxoacids. It is also a component in the glycine cleavage system.
Conner, Mark Joseph Alexander
core   +1 more source

Novel mutations in a boy with dihydrolipoamide dehydrogenase deficiency.

open access: yesMedical science monitor : international medical journal of experimental and clinical research, 2002
Dihydrolipoamide dehydrogenase (DLD) deficiency is a rare cause of primary lactic acidosis in infancy.This article presents the results of biochemical and molecular analyses and metabolic response to treatment procedures in a 10-week old boy presenting with vomiting, progressive hypotonia, lactic acidosis (pH 7.04; BE - 20; B-lactate 6.6 mmol/l ...
L, Cerna   +7 more
openaire   +1 more source

Dihydrolipoamide Dehydrogenase (DLD) Deficiency: A Case Report

open access: yes
Abstract Background: Dihydrolipoamide dehydrogenase deficiency (DLDD) is a rare autosomal-recessive mitochondrial disorder that may present as episodic hepatic crises with full recovery between attacks, leading to delayed diagnosis. Case presentation: A 7-year-old boy from Jordan had recurrent monthly episodes of abdominal pain and ...
Eman Awady   +6 more
openaire   +1 more source

Rewriting Tumor Immunity With Bacterial Membrane Vesicles: A Versatile and Potent Therapeutic Strategy

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 10, October 2026.
Bacterial membrane vesicles (BMVs) emerge as promising platforms for cancer immunotherapy owing to their intrinsic adjuvant properties and tunable cargo delivery capabilities. Their ability to modulate the tumor microenvironment, enhance antitumor immune responses, and support personalized therapeutic strategies highlights their growing potential as ...
Md Sifat Rahi   +6 more
wiley   +1 more source

Gut Enterococcus faecium derived leucic acid mediates the antiobesity effect of dietary fiber

open access: yesiMeta, Volume 5, Issue 5, October 2026.
This study identified Enterococcus faecium as a gut bacterium with anti‐obesity activity, which alleviated adipocyte hypertrophy, dyslipidemia, and hepatic steatosis by converting leucine into leucic acid (LEA) to regulate mitochondrial oxidative phosphorylation.
Baifei Hu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy